Profile
Rob Slack is currently Chief Scientific Officer at Vicore Pharma Holding AB since 2026.
Formerly, Dr. Slack was Vice President & Head-Respiratory Biology at GSK Plc and Chief Scientific Officer at Damora Therapeutics, Inc. Dr. Slack earned a doctorate from the University of Strathclyde.
Rob Slack active positions
| Companies | Position | Start |
|---|---|---|
| VICORE PHARMA HOLDING AB | Chief Tech/Sci/R&D Officer | 2026-07-05 |
Former positions of Rob Slack
| Companies | Position | End |
|---|---|---|
| GSK PLC | Corporate Officer/Principal | - |
| DAMORA THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | - |
Training of Rob Slack
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 4 |
|---|---|
GSK Plc
GSK Plc Pharmaceuticals: MajorHealth Technology Develops, manufactures and distributes vaccines and other pharmaceutical products | Health Technology |
University of Strathclyde
University of Strathclyde Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Vicore Pharma Holding AB
Vicore Pharma Holding AB Pharmaceuticals: MajorHealth Technology Engages in research and development of drugs for lung diseases | Health Technology |
Galecto, Inc.
Galecto, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs for treatment of severe diseases | Health Technology |
- Stock Market
- Insiders
- Rob Slack
















